Back to Ameriprise Financial Inc. Ameriprise Financial Inc.

SAVASAVA

Showing 4 of 18 quarters

Position history for Ameriprise Financial Inc.Ameriprise Financial Inc.'s holdings in FILANA THERAPEUTICS INC

No. Ameriprise Financial exited its SAVA (Filana Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 15,374 shares worth $23,062. Ameriprise Financial first reported SAVA in Q4 2020 and held it in 16 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$527,856

Total Shares Change

-17,936

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$1.81
0
2025-Q1
Decreased
15,374
-3.8%
$23,0620.0%$1.50
0
2024-Q4
Decreased
15,973
-10.9%
$37,6960.0%$2.36
0
2024-Q3
Decreased
17,936
-10.3%
$527,8560.0%$29.43
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used